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The true story behind the annotation of 
a pathway
Giovanni Dall'Olio,
IBE (UPF-CEXS)
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Summary of the talk
● We have recently published two works:
● Dall'Olio GM, Jassal B, Montanucci L, Gagneux P, Bertranpetit J, 
Laayouni H. The annotation of the Asparagine N-linked 
Glycosylation pathway in the Reactome Database. Glycobiology. 
2011 Jan 2. PubMed PMID: 21199820.
● Dall'Olio GM, Bertranpetit J, Laayouni H. The annotation and the 
usage of scientific databases could be improved with public issue 
tracker software. Database (Oxford). 2010 Dec 23;2010:baq035. Print 
2010. PubMed PMID: 21186182; PubMed Central PMCID: 
PMC3011984.
● One is about the annotation of a pathway in a 
database, the other about reporting errors to 
databases
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What can you learn from this talk
● The data annotated in scientific databases is 
not perfect, and can contain errors. Even when 
is correct, it can have multiple interpretations.
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What can you learn from this talk
● The data annotated in scientific databases is 
not perfect, and can contain errors. Even when 
is correct, it can have multiple interpretations.
● Errors don't get fixed by themselves, and 
problems don't get solved alone. When you find 
something wrong, it is your duty to report it.
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What is N-Glycosylation?
● One of the most 
important forms of 
protein modification
● A complex sugar 
composed by 14 units is 
attached to a protein, 
and later modified.
protein
Cell membrane
N-glycans
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What is N-Glycosylation? (II)
● The surface of a cell is 
usually covered by N-
glycosylated proteins
● It enhances solubility 
and is required for the 
proper folding. 
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N-Glycosylation – how does it works
● A common N-Glycan precursor is attached to a 
nascent protein, and then modified
N-glycan 
precursor
Intermediate 
N-glycan
Millions of
different N-
glycans
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Advanced N-Glycosylation
● The same protein can have different N-
Glycosylation on different tissues and times
Protein A in the 
morning
Protein A in the 
evening
Protein A during a 
party
Protein A on an  
  eritrocite
Protein A on a 
  epithelial cell
Protein A on a dead 
cell
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N-Glycosylation is a text-book 
example
● The first part of this 
pathway was  
characterized in the 1980's 
by random mutagenesis in 
yeast (the ALG mutants) 
● N-glycosylation is 
important to 
biotechnologists because 
of its implications for drugs 
biosynthesisNatu
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Annotating the pathway
● My PhD thesis is about selection within the 
genes of N-Glycosylation, so I had to study the 
biology behind it
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Annotating the pathway
● My PhD thesis is about selection within the 
genes of N-Glycosylation, so I had to study the 
biology behind it
● I was not happy with the current annotation of 
the pathway in other databases, so I decided to 
make a new annotation by myself, and publish 
it on a public database
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Reactome
● A database for biological relevant pathways
● TCA cycle, apoptosis, telomerases, influenza...
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Reactome - advantages
● Open-source approach. Anyone can contribute 
to a pathway, and all contributions are public 
and transparent
● Annotates a greater number of informations for 
each reaction
● Does not artificially distinguish between 
metabolic/interaction pathways (uses GO terms 
instead)
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The process of annotation in 
Reactome
● Annotating a pathway in Reactome means that 
for each reaction, you have to details like:
● Description and name of the reaction
● Genes involved
● GO localization terms for input, outputs and 
enzymes
● References to experimental evidences
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The process of annotation in 
Reactome
Our N-Glycosylation pathway
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The process of annotation in 
Reactome
● Annotating a pathway in Reactome means that 
for each reaction, you have to provide details 
like:
● Description and name of the reaction
● Genes involved
● GO localization terms for input, outputs and 
enzymes
● References to experimental evidences
● Each reaction must pass a peer-reviewed 
process before being included in Reactome
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N-Glycosylation on Reactome 
final result
● It tooks about 6 months of work to annotate the 
pathway 
● ~100 reactions
● lot of literature read
● problems with entries in other databases
● technical implementation problems
● problems, problems, problems, time wasted 
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Is it worth to annotate a pathway 
manually as I did?
● If you are a PhD student: probably yes, and at the 
beginning
● Pros:
● Helps you having good ideas
● Recognize how much you can trust database 
annotations
● Can be published
● Cons:
● Takes time
● Not feasible for larger scale studies
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The Reactome pathway, complete
http://tinyurl.com/nglyco-reactome
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N-Glycosylation in other databases
● Historically, this pathway is well characterized 
and is a textbook example of a metabolic 
pathway
● It is a good example to compare its annotations 
in different databases
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N-Glycosylation in other databases
● Historically, this pathway is well characterized 
and is a textbook example of a metabolic 
pathway
● It is a good example to compare its annotations 
in different databases
● If you dedicate 6 months to read tons of 
literature about what you are studying, which 
kind of errors do you expect to find in 
databases?
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GeneOntology (GO)
● GO is an ontology of terms to 
describe the function, localization 
of a gene 
● A dictionary designed to reduce 
the problem of synonyms and 
unclear terminology
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What is a GO annotation?
● A GO annotation is the association between a 
GO term and a gene, protein or event
● The gene ALG1 is Integral to the membrane (GO: 
32130)
● The protein XYZ has peroxidase activity 
(GO:03123)
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GO annotations
● GO annotations are frequently used in the 
scientific literature
● This set of genes is enriched of a specific GO term
● We subdivided the pathway in GO modules and 
studied selection within them
● However, which are the procedures to 
associate a GO term with a gene?
● Which are the possible sources of error in a GO 
association?
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The GO term assignment
● In order to assign a GO term to a protein in a 
species, there it must be an experimental 
evidence for the association in that species
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The GO term assignment
● In order to assign a GO term to a protein in a 
species, there it must be an experimental 
evidence for the association in that species
Lots of false negatives in GO!
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Example of false negative in GO
● We proposed the association of DPAGT1 with 
the  term 'Integral to the ER membrane' in 
human
● All the literature assumes that this association 
exists
● This association is annotated in Kegg for Yeast
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Example of false positive in GO
● We proposed the association of DPAGT1 with 
the  term 'Integral to the ER membrane' in 
human
● All the literature assumes that this association 
exists
● This association is annotated in Kegg for Yeast
● The proposal has been rejected because there 
it were no experimental evidence in human
● Probably there it won't never be any
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DPAGT1  on GO issue tracker
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
11
.5
56
1.
1 
: P
os
te
d 
18
 J
an
 2
01
1
  
Ambigous interpretation of the term 
N-Glycosylation in GO
● We found a big mistake with the term 'N-
Glycosylation'
● This was being associated to two classes of 
genes: those which are glycosylated, and those 
which participate to the process of glycosylation
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
11
.5
56
1.
1 
: P
os
te
d 
18
 J
an
 2
01
1
  
Ambigous interpretation of the term 
N-Glycosylation in GO
N-Glycosylated protein
World J Gastroenterol. 2010 December 21; 16(47): 5916-
5924. 
N-Glycosylation pathway
Essentials of Glycobiology, 3rd edition
merged
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Summary of GO annotations for N-
glycosylation
● ~80 correct GO classification
● ~50 new gene-term association proposed
● 10 genes had a clearly wrong classification
● 2 new GO terms proposed:
● Endoplasmic reticulum quality control compartment
● Intrinsic to the lumenal side of the endoplasmic 
reticulum :-)
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The GO issue tracker
● All the errors on GO elements are tracked on a 
publicly accessible online application, the issue 
tracker
● From there, you can report new errors, or check 
whether there are reported cases for the terms 
you are using
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The GO tracker
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KEGG/Pathways
● A database of 
Pathways, curated by 
experts in the field 
and manually drawn
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KEGG/Pathway
● KEGG/Pathways is the most renowned 
database for biological pathways
● Pros:
● Lot of pathways annotated
● Cons:
● Authors of the pathways are unknown, and no 
references are given for each reaction. Difficult to 
ask for clarificationNatu
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N-Glycosylation on KEGG
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KEGG/Pathways
● KEGG/pathways 
diagrams show a 
simplified version of 
the pathway
● These diagrams are 
not wrong, but they 
are there for 
visualization only. 
● Easy to interpret them 
erroneously
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This is how the latter part of the 
pathway really looks like:
Advanced N-Glycosylation 
in KEGG
Real represenation of 
advanced N-Glycosylation
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Why it is important to have 
references for reactions
● For our knowledge of the 
literature, there it should be 
a trifurcation at this point
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Why it is important to have 
references for reactions
● For our knowledge of the 
literature, there it should be 
a trifurcation at this point
● Instead, it is shown here:
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Why it is important to have 
references for reactions
● For our knowledge of the 
literature, there it should be a 
triple bifurcation at this point
● Instead, it is shown here:
● Without references, it is 
impossible to know why the 
annotator put the bifurcation 
there
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String
● Database of interactions among proteins
● Collects informations from different resources 
and merge them together (example of meta-
database)
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False positives in interactions 
databases
● Interaction databases are usually full of false 
positives and negatives
● Yeast-two hybrids and similar
● Automatic processing of scientific papers
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String – the pathway is not there
● Most of the interactions in N-Glycosylation were 
not found in String
● Latest release has improved
● The same term interaction is ambiguous
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String, the ALG2 case
● The biggest issue we 
found in String was due to 
two genes with similar 
names
● There are two genes with 
the symbol ALG2:
● ALG2 (Asparagine Linked 
Glycosylation 2) 
● ALG-2 (Apoptosis Linked 
Gene – 2)
● In string, these two were 
confused
ALG2 ALG-2
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The ALG11 case
● Similar case for 
ALG11
● Was confused with 
ALG11, a 
Ribonucleosomal 
protein
ALG11
(N-Glycosylation)
ALG11
(Ribonucleosomal protein)
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What's wrong with String
● The main problem with String is not that there 
are many false positives/negatives,
● rather, is that there is no way to annotate or 
report wrong interactions
● It would be good if I could 
tell other users about these 
false positives
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Uniprot
● Uniprot is a database for annotations of 
proteins
● The standard resource to use when looking for 
information on a protein
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Annotations in Uniprot
● We have found very few errors in the 
annotations in Uniprot
● Mostly they were due to outdated names or 
minor imprecisions
● Every Uniprot entry has a 'Send me feedback' 
button
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So, I have found an error in an 
annotation – now what?
● Ignore the error
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So, I have found an error in an 
annotation – now what?
● Ignore the error
● Wrong because the error remains there and can 
affect other people's work
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So, I have found an error in an 
annotation – now what?
● Ignore the error
● Wrong because the error remains there and can 
affect other people's work
● Use a different database
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So, I have found an error in an 
annotation – now what?
● Ignore the error
● Wrong because the error remains there and can 
affect other people's work
● Use a different database
● Even worst than the previous: doesn't fix the error 
and waste times
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So, I have found an error in an 
annotation – now what?
● Ignore the error
● Wrong because the error remains there and can 
affect other people's work
● Use a different database
● Even worst than the previous: doesn't fix the error 
and waste times
● Report the error
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So, I have found an error in an 
annotation – now what?
● Ignore the error
● Wrong because the error remains there and can 
affect other people's work
● Use a different database
● Even worst than the previous: doesn't fix the error 
and waste times
● Report the error
● This is the best approach, however not everybody 
knows how to do it, and it requires time
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Current state of reporting errors in 
the scientific community
● Unfortunately, reporting errors is not 
encouraged in the modern scientific literature
● Time consuming, but not acknowledged
● Few people know how to do it
● Made difficult by lack of transparency
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Issue trackers
● Usually the best way to report an error is by 
using an issue tracker software
● When you find an error in a database, always 
check whether there is a public issue tracker
● If not, things get more difficult
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How to report an error in GO
● Check the instructions
● Verify the error has not 
been reported yet
● Go to the tracker Home 
page, and click on 
'Report new issue'
● Describe the problem 
with a good title and 
references
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Take-home messages
● Before using any data from a scientific 
database:
● Check whether they have a public issue tracker and 
check whether there are errors reported about your 
data
● Read the literature!
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